dc.contributor.author |
Rassaf T |
|
dc.contributor.author |
Ferdinandy, Péter |
|
dc.contributor.author |
Schulz R |
|
dc.date.accessioned |
2014-12-23T09:34:46Z |
|
dc.date.available |
2014-12-23T09:34:46Z |
|
dc.date.issued |
2014 |
|
dc.identifier |
84890287929 |
|
dc.identifier.citation |
pagination=1-11;
journalVolume=171;
journalIssueNumber=1;
journalTitle=BRITISH JOURNAL OF PHARMACOLOGY; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/897 |
|
dc.identifier.uri |
doi:10.1111/bph.12291 |
|
dc.description.abstract |
In the last decade, the nitrate-nitrite-nitric oxide (NO) pathway has emerged to therapeutical importance. Modulation of endogenous nitrate and nitrite levels with the subsequent S-nitros(yl)ation of the downstream signalling cascade open the way for novel cytoprotective strategies. In the following we summarize the actual literature and give a short overview on the potential of nitrite in organ protection. |
|
dc.relation.ispartof |
urn:issn:0007-1188 |
|
dc.title |
Nitrite in Organ Protection |
|
dc.type |
Journal Article |
|
dc.date.updated |
2014-12-23T08:32:27Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
2380517 |
|
dc.identifier.wos |
000328014400001 |
|
dc.identifier.pubmed |
23826831 |
|
dc.contributor.department |
SE/ÁOK/I/Farmakológiai és Farmakoterápiás Intézet |
|
dc.contributor.institution |
Semmelweis Egyetem |
|